Boston Family Office LLC Bristol Myers Squibb CO Transaction History

Boston Family Office LLC

$1.39 Billion
Q2 2024

A detailed history of Boston Family Office LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boston Family Office LLC holds 24,179 shares of BMY stock, worth $1.29 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

24,179

Previous 24,179 -0.0%

Holding current value

$1.29 Million

Previous $1.31 Million 23.42%

% of portfolio

0.07%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $112,944 - $128,057	-2,354 Reduced 8.87%	24,179 $1.31 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $139,040 - $165,913	-2,868 Reduced 9.75%	26,533 $1.36 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $44,227 - $49,453	764 Added 2.67%	29,401 $1.71 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $115,386 - $130,874	1,756 Added 6.53%	28,637 $1.98 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $38,348 - $45,410	-560 Reduced 2.04%	26,881 $1.93 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $27 - $16,213	-211 Reduced 0.76%	27,441 $1.95 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $19,970 - $21,994	-275 Reduced 0.98%	27,652 $2.13 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $14,748 - $17,193	275 Added 0.99%	27,927 $1.74 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $12,382 - $13,484	-200 Reduced 0.72%	27,652 $1.85 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $726,262 - $816,830	-12,239 Reduced 30.53%	27,852 $2.53 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $78,988 - $89,508	-1,368 Reduced 3.3%	40,091 $2.49 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $37,042 - $41,047	-645 Reduced 1.53%	41,459 $2.5 Million
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $38,374 - $44,863	-700 Reduced 1.64%	42,104 $2.48 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $221,560 - $321,978	-4,775 Reduced 10.04%	42,804 $2.39 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $367,401 - $479,242	7,466 Added 18.61%	47,579 $3.05 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $42,770 - $50,710	-1,000 Reduced 2.43%	40,113 $2.03 Million
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $12,588 - $15,010	-279 Reduced 0.67%	41,113 $1.96 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $34,132 - $44,261	-700 Reduced 1.66%	41,392 $2.15 Million
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $13,137 - $16,374	-260 Reduced 0.61%	42,092 $2.33 Million
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $89,790 - $97,894	1,498 Added 3.67%	42,352 $2.6 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $2.26 Million - $2.6 Million	40,854	40,854 $2.6 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Account

Boston Family Office LLC Bristol Myers Squibb CO Transaction History